Low Level FLT3LG is a Novel Poor Prognostic Biomarker for Cervical Cancer with Immune Infiltration.

Lihua ChenYuxuan HuangBinhua DongYu GuYe LiWei CangPeng-Ming Sun Yang Xiang

Published in: Journal of inflammation research (2022)

Research on FLT3LG provided insight into its critical function. Hence, the low expression of FLT3LG may be a valuable biomarker in CESC patients linked with immune infiltration.

Keyphrases

acute myeloid leukemia
tyrosine kinase
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported outcomes